What DocuSign (DOCU)'s ChatGPT Integration Means For Shareholders

• In late October 2025, DocuSign announced it will integrate its Intelligent Agreement Management platform with OpenAI's ChatGPT using the Model Context Protocol, allowing users to create, analyze, and manage contracts directly within the AI chatbot environment.
• This development embeds agreement workflows into one of the world's most popular AI tools and signals a move to streamline contract management within conversational AI platforms.
• We'll now examine how embedding DocuSign's AI-powered agreement tools within ChatGPT could reshape its long-term investment outlook.

This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.

DocuSign Investment Narrative Recap

To be a DocuSign shareholder, you need to believe that digital agreement platforms with AI-powered features will continue growing as organizations modernize workflows and tighten compliance needs. The new ChatGPT integration may signal progress on enterprise and AI-based upsell opportunities, but does not appear to materially change the primary near-term catalyst: rapid adoption of the Intelligent Agreement Management (IAM) platform by DocuSign's massive install base, and this remains a key challenge with unclear adoption rates and economic uplift.

Among recent announcements, the September 2025 launch of biometric identity verification with CLEAR stands out as most relevant to the ChatGPT integration, since both focus on enhancing trust, security, and user experience in digital contracting. These moves are critical as DocuSign aims to maintain leadership in a market where retention and stickiness underpin all growth levers and help defend against mounting competitive risks.

Yet, despite these growth efforts, investors should also weigh the risk that DocuSign’s projected revenue increases may not offset gradually shrinking margins if...

Read the full narrative on DocuSign (it's free!)

DocuSign's outlook anticipates $3.8 billion in revenue and $359.8 million in earnings by 2028. This implies a 7.3% annual revenue growth and a $78.8 million increase in earnings from the current $281.0 million.

Uncover how DocuSign's forecasts yield a $93.16 fair value, a 27% upside to its current price.

Exploring Other Perspectives

Six Simply Wall St Community members set fair values for DocuSign between US$77 and US$118.15 per share. With consensus now focused on new AI integrations, you might see these opinions shift and should check several viewpoints before deciding.

Explore 6 other fair value estimates on DocuSign - why the stock might be worth just $77.00!

Build Your Own DocuSign Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your DocuSign research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free DocuSign research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DocuSign's overall financial health at a glance.

Interested In Other Possibilities?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 27 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Find companies with promising cash flow potential yet trading below their fair value.
• These 16 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com